If your practice or organization feels threatened by this shift, you now have the chance for your voice to be heard before the nation’s highest court.
The Supreme Court of the United States is considering Naum v. United States, a case that calls for putting a definitive standard in place for prescribing controlled substances in the U.S. This would address the vagueness of 21 U.S.C. § 841(a)(1) and 21 C.F.R. § 1306.04 and eliminate any ambiguity when federal circuits are asked to consider whether a pain management specialist (or any other practitioner) ceased to act as a physician and instead served as a drug dealer.
The argument is authored by Ronald W. Chapman II, who represents the defendant in Naum. As chairperson of the White Collar Defense & Government Investigations practice at Chapman Law Group, Chapman has faced this legal argument in several federal circuits. In Naum, the U.S. Supreme Court has a case that is representative of why a definitive standard must be put in place.
We are calling on you to show your support of this crucial legal issue, by way of an Amicus Brief. This is an issue that affects you and your constituents directly, and it will clarify how the criminal law procedure applies to the practice of not just pain medicine, but overall medical practice.
You may find the brief for Naum v. United States here. We appreciate your consideration in helping the high court understand how much is at stake for the many members of pain management medical community, and, just as important, the patients who rely on them.